======= RANGAP1 ======= == Gene Information == * **Official Symbol**: RANGAP1 * **Official Name**: Ran GTPase activating protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5905|5905]] * **UniProt**: [[https://www.uniprot.org/uniprot/P46060|P46060]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RANGAP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RANGAP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602362|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: GTPase activator for the nuclear Ras-related regulatory protein Ran, converting it to the putatively inactive GDP-bound state. |RanGAP1 C| |cytoplasmic periphery of the nuclear pore complex| |response to vasopressin| |cellular response to vasopressin| |nuclear pore cytoplasmic filaments| |negative regulation of protein export from nucleus| |negative regulation of nucleocytoplasmic transport| |maintenance of protein location in nucleus| |Ran GTPase binding| |regulation of protein export from nucleus| |maintenance of protein localization in organelle| |negative regulation of intracellular protein transport| |aggresome| |response to axon injury| |axon cytoplasm| |negative regulation of intracellular transport| |protein sumoylation| |nuclear pore| |maintenance of protein location in cell| |mitotic spindle| |kinetochore| |condensed chromosome kinetochore| |maintenance of location in cell| |activation of GTPase activity| |regulation of nucleocytoplasmic transport| |maintenance of protein location| |negative regulation of cellular protein localization| |protein localization to nucleus| |maintenance of location| |nuclear envelope| |negative regulation of protein transport| |negative regulation of establishment of protein localization| |regulation of intracellular protein transport| |nuclear membrane| |cellular response to peptide hormone stimulus| |GTPase activator activity| |ubiquitin protein ligase binding| |cadherin binding| |peptidyl-lysine modification| |cellular response to peptide| |regulation of intracellular transport| |response to peptide hormone| |positive regulation of GTPase activity| |dendrite| |response to peptide| |regulation of GTPase activity| |negative regulation of transport| |regulation of cellular protein localization| |response to wounding| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |cellular response to nitrogen compound| |intracellular membrane-bounded organelle| |perinuclear region of cytoplasm| |regulation of protein transport| |protein localization to organelle| |regulation of peptide transport| |regulation of establishment of protein localization| |positive regulation of hydrolase activity| |protein modification by small protein conjugation| |peptidyl-amino acid modification| |response to hormone| |regulation of cellular localization| |protein modification by small protein conjugation or removal| |response to organonitrogen compound| |regulation of protein localization| |cellular response to oxygen-containing compound| |response to nitrogen compound| |cellular response to endogenous stimulus| |regulation of hydrolase activity| |RNA binding| |positive regulation of catalytic activity| |response to endogenous stimulus| |response to oxygen-containing compound| |cellular protein localization| |cellular macromolecule localization| |positive regulation of molecular function| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|-1.98| |[[:results:exp475|CyclicAMP 200μM R08 exp475]]|1.72| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|1.72| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|1.74| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|1.8| |[[:results:exp235|Geldanamycin 0.01μM R05 exp235]]|1.83| |[[:results:exp261|ABT-702 5μM R06 exp261]]|1.84| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.84| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.91| |[[:results:exp69|Deguelin 0.05μM R02 exp69]]|1.94| |[[:results:exp90|WYE-354 6μM R02 exp90]]|2.16| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|2.18| |[[:results:exp376|Losmapimod 1μM R07 exp376]]|2.3| |[[:results:exp481|Ethambutol 25μM R08 exp481]]|2.36| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.39| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|2.41| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.512| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.45| |[[:human genes:p:psmb2|PSMB2]]|0.45| |[[:human genes:n:nupl1|NUPL1]]|0.442| |[[:human genes:p:psmb4|PSMB4]]|0.434| |[[:human genes:r:rrn3|RRN3]]|0.426| |[[:human genes:n:nup153|NUP153]]|0.417| |[[:human genes:t:tceb3c|TCEB3C]]|0.416| |[[:human genes:c:cdca3|CDCA3]]|0.413| |[[:human genes:s:stil|STIL]]|0.413| |[[:human genes:z:znf830|ZNF830]]|0.412| |[[:human genes:s:slc6a17|SLC6A17]]|0.411| |[[:human genes:c:cdc45|CDC45]]|0.411| |[[:human genes:c:cnot3|CNOT3]]|0.41| |[[:human genes:p:polr2f|POLR2F]]|0.408| |[[:human genes:t:tbc1d3g|TBC1D3G]]|0.407| |[[:human genes:p:psmb3|PSMB3]]|0.405| |[[:human genes:r:ranbp2|RANBP2]]|0.405| |[[:human genes:v:vps28|VPS28]]|0.403| |[[:human genes:p:psma6|PSMA6]]|0.401| |[[:human genes:t:ticrr|TICRR]]|0.401| Global Fraction of Cell Lines Where Essential: 450/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|22/28| |blood|21/28| |bone|13/26| |breast|23/33| |central nervous system|35/56| |cervix|3/4| |colorectal|12/17| |esophagus|8/13| |fibroblast|1/1| |gastric|11/16| |kidney|8/21| |liver|11/20| |lung|52/75| |lymphocyte|14/16| |ovary|15/26| |pancreas|18/24| |peripheral nervous system|5/16| |plasma cell|12/15| |prostate|1/1| |skin|15/24| |soft tissue|5/9| |thyroid|1/2| |upper aerodigestive|9/22| |urinary tract|16/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 664 * **Expression level (log2 read counts)**: 7.57 {{:chemogenomics:nalm6 dist.png?nolink |}}